741 related articles for article (PubMed ID: 30927950)
41. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
[TBL] [Abstract][Full Text] [Related]
42. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction.
Greulich S; Kitterer D; Latus J; Aguor E; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Mayr A; Braun N; Alscher MD; Sechtem U; Mahrholdt H
Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903537
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study.
Mayr A; Kitterer D; Latus J; Steubing H; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H; Greulich S
J Cardiovasc Magn Reson; 2016 Oct; 18(1):67. PubMed ID: 27733210
[TBL] [Abstract][Full Text] [Related]
45. Myocardial Native T
Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
[TBL] [Abstract][Full Text] [Related]
46. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
Dolan RS; Stillman AE; Davarpanah AH
Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
[TBL] [Abstract][Full Text] [Related]
47. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
[TBL] [Abstract][Full Text] [Related]
48. Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique.
Dastidar AG; Harries I; Pontecorboli G; Bruno VD; De Garate E; Moret C; Baritussio A; Johnson TW; McAlindon E; Bucciarelli-Ducci C
Int J Cardiovasc Imaging; 2019 Mar; 35(3):517-527. PubMed ID: 30357547
[TBL] [Abstract][Full Text] [Related]
49. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation.
Mordi I; Carrick D; Bezerra H; Tzemos N
Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):797-803. PubMed ID: 26358692
[TBL] [Abstract][Full Text] [Related]
50. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping.
Thavendiranathan P; Walls M; Giri S; Verhaert D; Rajagopalan S; Moore S; Simonetti OP; Raman SV
Circ Cardiovasc Imaging; 2012 Jan; 5(1):102-10. PubMed ID: 22038988
[TBL] [Abstract][Full Text] [Related]
51. Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study.
Treiber J; Novak D; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Weferling M; von Jeinsen B; Hain A; Rieth AJ; Siemons T; Keller T; Hamm CW; Rolf A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):8. PubMed ID: 36755275
[TBL] [Abstract][Full Text] [Related]
52. Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications.
Meloni A; Martini N; Positano V; De Luca A; Pistoia L; Sbragi S; Spasiano A; Casini T; Bitti PP; Allò M; Sanna PMG; De Caterina R; Sinagra G; Pepe A
J Cardiovasc Magn Reson; 2021 Jun; 23(1):70. PubMed ID: 34120634
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).
Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC
J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886
[TBL] [Abstract][Full Text] [Related]
54. Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
Starc JJ; Moore RA; Rattan MS; Villa CR; Gao Z; Mazur W; Jefferies JL; Taylor MD
Pediatr Cardiol; 2017 Oct; 38(7):1485-1492. PubMed ID: 28762167
[TBL] [Abstract][Full Text] [Related]
55. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.
Kim JY; Hong YJ; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
Korean J Radiol; 2021 Jun; 22(6):880-889. PubMed ID: 33686816
[TBL] [Abstract][Full Text] [Related]
56. Ventricular function and tissue characterization by cardiac magnetic resonance imaging following hospitalization for multisystem inflammatory syndrome in children: a prospective study.
DiLorenzo MP; Farooqi KM; Shah AM; Channing A; Harrington JK; Connors TJ; Martirosyan K; Krishnan US; Ferris A; Weller RJ; Farber DL; Milner JD; Gorelik M; Rosenzweig EB; Anderson BR;
Pediatr Radiol; 2023 Mar; 53(3):394-403. PubMed ID: 36255453
[TBL] [Abstract][Full Text] [Related]
57. Multiparametric cardiac magnetic resonance reveals persistent myocardial inflammation in patients with exertional heat illness.
Luo S; Xu ST; Zhang J; Schoepf UJ; Varga-Szemes A; Carpenter CRT; Zhang LY; Ma Y; Li Z; Wang Y; Huang WW; Zhi BB; Dou WQ; Qi L; Zhang LJ
Eur Radiol; 2023 Nov; 33(11):8165-8176. PubMed ID: 37145150
[TBL] [Abstract][Full Text] [Related]
58. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
[TBL] [Abstract][Full Text] [Related]
59. Assessment of myocardial injuries in ischaemic and non-ischaemic cardiomyopathies using magnetic resonance T1-rho mapping.
Bustin A; Pineau X; Sridi S; van Heeswijk RB; Jaïs P; Stuber M; Cochet H
Eur Heart J Cardiovasc Imaging; 2024 Mar; 25(4):548-557. PubMed ID: 37987558
[TBL] [Abstract][Full Text] [Related]
60. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
